Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,505 EUR | -3,53% | +3,08% | -62,38% |
28/03 | Bel20 met winst naar de paasvakantie | AM |
28/03 | Brussel licht hoger | AM |
Omzet 2023 * | 888K 957K | Omzet 2024 * | 653K 704K | Marktkapitalisatie | 42,51 mln. 45,8 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | -31 mln. -33,4 mln. | Nettowinst (verlies) 2024 * | -23 mln. -24,78 mln. | EV/omzet 2023 * | 61,2 x |
Nettoschuld 2023 * | 11,85 mln. 12,77 mln. | Nettoschuld 2024 * | 29,45 mln. 31,73 mln. | EV/omzet 2024 * | 110 x |
K/w-verhouding 2023 * |
-1,35
x | K/w-verhouding 2024 * |
-1,5
x | Werknemers | 70 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 76,56% |
Recentste transcriptie over Sequana Medical N.V.
1 dag | -3,53% | ||
1 week | +3,08% | ||
Lopende maand | -37,03% | ||
1 maand | -39,80% | ||
3 maanden | -61,51% | ||
6 maanden | -50,17% | ||
Lopend jaar | -62,38% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ian Crosbie
CEO | Chief Executive Officer | 56 | 01-01-16 |
Director of Finance/CFO | 50 | - | |
Andreas Wirth
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Douglas Kohrs
BRD | Director/Board Member | 66 | 19-07-22 |
Wim Ottevaere
BRD | Director/Board Member | 68 | 08-11-18 |
Ids van der Weij
BRD | Director/Board Member | - | 10/11 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 1,505 | -3,53% | 392 609 |
27-03-24 | 1,56 | -3,70% | 137 032 |
26-03-24 | 1,62 | -4,71% | 217 348 |
25-03-24 | 1,7 | +10,03% | 516 687 |
22-03-24 | 1,545 | +5,82% | 387 433 |
Real Time Euronext Bruxelles, 28 maart 2024 om 17:35 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-62,38% | 47,67 mln. | |
+9,30% | 45,97 mld. | |
+52,73% | 43,93 mld. | |
+7,15% | 42,34 mld. | |
-8,78% | 28,27 mld. | |
+18,68% | 27,18 mld. | |
-21,92% | 19,44 mld. | |
+14,62% | 13,83 mld. | |
+31,85% | 12,4 mld. | |
+4,47% | 11,45 mld. |